EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects

EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects

Abstract The frequency of the use of drugs that act on the epidermal growth factor receptor (EGFR) is increasing, with the consequent onset of cutaneous toxicity, specifically acneiform eruption. The authors extensively review the topic, focusing on describing how these drugs can affect the skin and...

Full description

Bibliographic Details
Main Authors: Júlia Kanaan Recuero, Joana Roberta Fitz, Andrea Abe Pereira, Renan Rangel Bonamigo
Format: Article
Language:English
Published: Sociedade Brasileira de Dermatologia 2023-08-01
Series:Anais Brasileiros de Dermatologia
Subjects:
Acneiform eruptions
Drug-related side effects and adverse reactions
Risk factors
Skin manifestations
Target therapy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000400429&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962023000400429&tlng=en

Similar Items